Advertisement

The Scientist

» industry and disease/medicine

Most Recent

image: Nanomedicine

Nanomedicine

By , , and | August 1, 2014

From bioimaging to drug delivery and therapeutics, nanotechnology is poised to change the way doctors practice medicine.

10 Comments

image: The Body’s Ecosystem

The Body’s Ecosystem

By | August 1, 2014

Research on the human microbiome is booming, and scientists have moved from simply taking stock of gut flora to understanding the influence of microbes throughout the body.

2 Comments

image: Reanimated Chickens and Zombie Dogs

Reanimated Chickens and Zombie Dogs

By | August 1, 2014

In praise of weird science at the edge of life

0 Comments

image: Next Generation: See-through Mice

Next Generation: See-through Mice

By | July 31, 2014

An improved tissue-clearing technique makes whole animals transparent.

1 Comment

image: A Blood-based Biomarker for Suicide?

A Blood-based Biomarker for Suicide?

By | July 31, 2014

Epigenetic and genetic changes in the SKA2 gene are correlated with suicidal behaviors, researchers show.

0 Comments

image: Are <em>Leishmania</em> Protecting their Sand Fly Hosts?

Are Leishmania Protecting their Sand Fly Hosts?

By | July 23, 2014

The microbial contents of sand fly stomachs may have important consequences for the spread of leishmaniasis.

0 Comments

image: Alzheimer’s in the Blood

Alzheimer’s in the Blood

By | July 23, 2014

Researchers are on a mission to identify blood-borne biomarkers for dementia. Will this year’s high-profile successes pave the way?

3 Comments

image: Autism in the Genes

Autism in the Genes

By | July 22, 2014

Researchers determine that heritability outweighs non-genetic risk factors when it comes to the developmental disorder.

0 Comments

image: Flipped Fat-burning Linked to Cancer Cachexia

Flipped Fat-burning Linked to Cancer Cachexia

By | July 22, 2014

Conversion of white fat to brown is associated with muscle atrophy and weight loss in cancer patients.

0 Comments

image: AbbVie Buys Shire for $54 Billion

AbbVie Buys Shire for $54 Billion

By | July 21, 2014

The massive pharma deal will create one of the 50 largest companies in the world, and will move AbbVie’s corporate tax headquarters from North Chicago to the U.K.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
Life Technologies